ABOUT MILLEFEUILLE

Millefeuille (or A Thousand Leaves) tells the story of Élodie, a French woman living a solitary and lonesome existence that has all but given up on her career as a pastry chef and has moved to London to escape from painful personal memories. Struggling with the effects of psoriasis and worsening psoriatic arthritis, Élodie one day meets Holly – the girl next door who, full of life and ambition, changes everything.

Millefeuille (or A Thousand Leaves) tells the story of Élodie, a French woman living a solitary and lonesome existence that has all but given up on her career as a pastry chef and has moved to London to escape from painful personal memories. Struggling with the effects of psoriasis and worsening psoriatic arthritis, Élodie one day meets Holly – the girl next door who, full of life and ambition, changes everything.

OUR INSPIRATION

Millefeuille is the culmination of extensive research in this space, highlighting a significant group of psoriasis and/or psoriatic arthritis sufferers who – like Élodie – struggle with the multiple aspects of their disease, but believe the status quo is the best they can hope for.

There are a number of people who are merely ‘coping’ rather than being satisfied with how their condition is managed, and many people with psoriasis withdraw from the health system. Some stop seeing their doctor or see them much less often, making it harder for people to get the help they need.1

We have heard first hand from patients that this experience can lead to deep unhappiness.2 We believe that ‘coping’ is not good enough and that people living with these complex diseases deserve more.

Millefeuille is also a story of triumph over adversity, hope and social acceptance. Élodie is shown on the fringes of society as she finds it difficult to handle the combination of her medical conditions and personal tragedy. Her story conveys a universal message of hope and friendship through times of suffering: something we can all relate to.

This year the World Health Organization (WHO) has released a global report on psoriasis, in a bid to bring the public health impact of this complicated condition into focus.3 Please watch and share the movie to help deepen society’s understanding of the challenges facing these communities.

You can read the WHO report and find out more about psoriasis, psoriatic arthritis and their complications by clicking here.

It’s like a ride where you cannot keep control of your head or your body – but I can’t get off – whatever I do I can’t make the ride stop.

Élodie

CAST & CREW

ACTORS

headshot-popup

Anne Parillaud Elodie

Anne Parillaud is a French award-winning actress. In 1991, she won a Cesar for Best Actress for her performance in La Femme Nikita,directed by Luc Besson. Anne has worked with international directors such as John Landis, Ettore Scola, Amos Gitai, Vincent Ward, Raoul Ruiz and Alfonso Arau. She also played with Leonardo Di Caprio in The Man in the Iron Mask as the actor’s mother.
View Anne Parillaud's IMDB profile
headshot$name

Anne Parillaud

Rosie Day Holly

Rosie Day is a British actress and one of Screen International’s ‘Stars of Tomorrow’. She can be seen playing a leading role opposite Sarah Jessica Parker in new feature film All Roads Lead to Rome. Her film credits include lead roles in The Seasoning House, Ironclad 2 and Sixteen and her television credits include Cuffs, Homefront and Misfits.
View Rosie Day's IMDB profile
Rosie Day- bw$name

Rosie Day
wolf hahler

Wolf Kahler Grandad

Wolf Kahler is a German actor born in Kiel. He came to England in 1970 and has since been a resident of London. One of his most well-known roles was that of Dietrich in The Raiders of the Lost Ark. In 2001 he portrayed a Wehrmacht General in the World War II TV miniseries, Band of Brothers. In 2011 Kahler appeared as Dr. Hoffmannsthal in Sherlock Holmes: A Game of Shadows.
View Wolf Kahler's IMDB Profile
wolf hahler$name

Wolf Kahler
PRODUCTION
al-clayton-popup

Alastair Clayton Director

Alastair started Turtle Canyon Films in 2002. After working in different roles on various short film projects for festivals and online release, in early 2015, Turtle Canyon Films teamed up with Bedrock Multimedia to produce Alastair’s award-winning short film In Memory, a love story focusing on an elderly couple coping with the daily struggle of advancing dementia. His sensitivity to the healthcare element of this story as well as his passion for telling a moving and human story made him the natural choice to helm Millefeuille.
View Alastair Clayton's IMDB Profile
Al-Clayton$name

Alastair Clayton

Isla Ure Screenwriter

Isla’s first short film Passengers was nominated for the BFI (British Film Institute) Future Film Award. She is currently writing military feature The Corps and London based feature, Spark.
View Isla Ure's IMDB Profile
isla-ure-1$name

Isla Ure

David Youds Producer

David is Owner and Managing Director of Bedrock Healthcare Communications. David has 15 years’ experience working for a number of leading companies in the healthcare industry. In 2010, David decided to lend his commercial experience to develop engaging communications programmes, founding Bedrock. Bedrock’s multimedia practice develops ’edutainment’ which aims to thrill, engage and teach audiences across healthcare issues.
View David Youds' IMDB profile
David Youds bw$name

David Youds
MEDICAL ADVISORS

Nikhil Yawalkar Medical Advisor

Nikhil Yawalkar is Associate Professor and Vice-Chairman at the Department of Dermatology, University of Bern, Switzerland. He is board-certified in Dermatology (1995) as well as Allergy and Clinical Immunology (1998) and has completed two postdoctoral research fellowships at the Department of Dermatology, UCSF School of Medicine, San Francisco and at the Harvard Skin Disease Research Center, Boston, USA.
His main research interests include immunological mechanisms in inflammatory skin diseases. He has over 100 publications in international peer-reviewed journals and is a member of various national and international professional societies.
Nikkhil Yawalkar$name

Nikhil Yawalkar

Dr. Ennio Lubrano di Scorpaniello MD, PHD Medical Advisor

Dr. Lubrano is an Aggregate Professor in Rheumatology at the University of Molise and Consultant Rheumatologist at Cardarelli Hospital, NHS, Campobasso, Italy. Dr. Lubrano is a leading expert in the field of rheumatology both in Italy and internationally and has authored/co-authored 75 publications.
He is also a member of several renowned professional bodies including; General Medical Council (GMC), Italian Society of Rheumatology (SIR) and GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis).
Ennio Lubrano bw$name

Dr. Ennio Lubrano di Scorpaniello MD, PHD
Behind the ScenesBehind the Scenes

play-icon Watch

BEHIND THE SCENES: THE MAKERS OF MILLEFEUILLE

   

Click on the images below to learn more about the award-winning production team behind Millefeuille.

  
celgeneblue-svg
turtleturtle-img
bedrockbedrock

BEHIND THE SCENES GALLERY

  • Carousel image

    1/12

    Millefeuille

    The translation of Millefeuille into English is ‘A Thousand Leaves’

1
2
3
4
5
6
7
8
9
10
11
12

References

  1. Lebwohl MG et al.Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey J Am Acad Dermatol 2014;70:871−81
  2. P.S.LIVE observational research. Ethnography project. 2014. Data on file
  3. World Health Organization. Global report on Psoriasis. 2016. http://apps.who.int/iris/bitstream/10665/204417/1/9789241565189_eng.pdf. Accessed March 2016
  4. Augustin M and The European Expert Working Group for Healthcare in Psoriasis. A framework for improving the quality of care for people with psoriasis. JEADV 2012, 26 (Suppl. 4), 1–16
  5. Psoriasis Association. About Psoriasis. Accessed March 2016. https://www.psoriasis-association.org.uk/pages/view/about-psoriasis
  6. Villasenor-Park j. et al. Psoriasis: Evolving treatment for a complex disease. Cleveland Journal of Medicine. Volume 79 (6) 2012
  7. International Federation of Psoriasis Associations. Psoriasis is a serious disease deserving global attention. 2012.
  8. American Academy of Dermatology. Psoriasis: Who gets and causes. 2015. Accessed March 2016 https://www.aad.org/dermatology-a-to-z/diseases-and-treatments/m---p/psoriasis/who-gets-causes
  9. Gladman, DD et al. Psoriatic arthritis: epidemiology, clinical features, course and outcome. Ann Rheum Dis. 2005;64(Suppl II):ii14–ii17. doi: 10.1136/ard.2004.032482
  10. Gottlieb A, Korman NJ, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol. 2008;58:851 864.
  11. Augustin M and The European Expert Working Group for Healthcare in Psoriasis. A framework for improving the quality of care for people with psoriasis. JEADV 2012, 26 (Suppl. 4), 1–16
  12. World Psoriasis Day Consortium. Facts about Psoriasis. Accessed March 2016. (http://www.worldpsoriasisday.com/web/page.aspx?refid=129)
  13. National Psoriasis Foundation. Scalp psoriasis. 2015. Accessed March 2016 (http://www.psoriasis.org/about-psoriasis/specific-locations/scalp)
  14. van de Kerkhof PC et al. Dermatology 1998;197:326–34
  15. De Vries AC et al. Cochrane Database Syst Rev. 2013; 1:CD007633
  16. Tan EST et al. Am J Clin Dermatol; 2012; 13(6):375–388.
  17. Reich K. J Eur Acad Dermatol Venereol 2009; 23(Suppl1):15–21.
  18. De Jong EMGJ et al. Dermatol 1996; 193:300–303.
  19. Yosipovitch et al. Br J Dermatol. 2000;143:969;
  20. Ritchlin C et al. Ann Rheum Dis 2014; 73(6):990–999.
  21. Ritchlin CT et al. Ann Rheum Dis 2009; 68:1387–1394.
  22. Mease PJ, Armstrong AW. Drugs 2014; 74(4):423–441.
  23. Arthritis Research UK. Entheses, enthesitis and enthesopathy. 2009. Accessed March 2016 (http://www.arthritisresearchuk.org/health-professionals-and-students/reports/topical-reviews/topical-reviews-autumn-2009.aspx)
  24. Arthritis Foundation. Psoriatic Arthritis Diagnosis. Accessed March 2016. http://www.arthritis.org/about-arthritis/types/psoriatic-arthritis/diagnosing.php
  25. Han, C., Robinson, D., Hackett, M., et al. Cardiovascular Disease and Risk Factors in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis. The Journal of Rheumatology. 2006; 33(11): 2167-72
  26. Armstrong, E., Harskamp, C., Armstrong, A. Psoriasis and Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Observational Studies. Journal of the American Heart Association. 2013; 2: e000062
  27. Bhosle M, Kulkarni A, Feldman S, Balkrishnan R. Quality of life in patients with psoriasis. Health Qual Life Outcomes. 2006;4(35)
  28. Gupta MA, Gupta AK. Psoriasis and sex: a study of moderate to severely affected patients. Int J Dermatol. April 1997;36(4):259-262
  29. Verstappen, S., Watson, K., Lunt, M., et al. Working Status in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis: Results from the British Society for Rheumatology Biologics Register. Rheumatology. 2010; 49(8): 1570‐1577.
  30. Tillett, W., de‐Vries, C., McHugh, N. Work Disability in Psoriatic Arthritis: A Systematic Review. Rheumatology. 2012; 51(2): 275‐283.
  31. Tara Fletcher. The Psychosocial Burden of Psoriasis. Psoriasis and Psoriatic Arthritis Alliance. 2013. http://www.papaa.org/articles/psychosocial-burden-psoriasis accessed March 2016
  32. Taylor Sofres. 1st World Psoriasis Day, 29 October 2004: New International Survey Shows People With Psoriasis Continue to be Rejected by Others. International Federation of Psoriasis Associations (IFPA). 2004
  33. National Psoriasis Foundation. Psoriasis Treatments. https://www.psoriasis.org/about-psoriasis/treatments accessed March 2016
  34. 67th World Health Assembly recognizes psoriasis as a serious non-communicable disease. World Health Assembly. 2014. http://news.cision.com/international-federation-of-psoriasis-associations/r/67th-world-health-assembly-recognizes-psoriasis-as-a-serious-non-communicable-disease,c9591315 accessed March 2016
  35. Augustin M and The European Expert Working Group for Healthcare in Psoriasis. A framework for improving the quality of care for people with psoriasis. JEADV 2012, 26 (Suppl. 4), 1–16
  36. World Psoriasis Day Consortium. Facts about Psoriasis. Accessed March 2016. (http://www.worldpsoriasisday.com/web/page.aspx?refid=129)